Additionally, it would be valuable to collect clinical samples and compare the expression levels of FGF3 in various molecular subtypes of breast cancer and normal breast tissue/benign breast lesions to explore the proportion of FGF3 overexpression in HBC. The gene discussed is FGF3; the disease is breast carcinoma.